Empasug 10mg - Empagliflozin 10 mg IR | Intralife Pharmaceuticals
DIASAGE
FeaturedTop

Empasug 10mg

MRP: 750

Packaging: 10X10

Pack Type: tablet

Composition:

Empagliflozin 10 mg IR

Indication:

Improves blood sugar control, Reduces cardiovascular death and hospitalization, Slows kidney disease progression and reduces heart risks

Description:

Empagliflozin 10mg IR is an oral antidiabetic medication belonging to the class of SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitors, used in the management of type 2 diabetes mellitus. It works by blocking the reabsorption of glucose in the kidneys, promoting glucose excretion through urine, thereby lowering blood sugar levels.

Apart from glycemic control, Empagliflozin also offers cardiovascular and renal protection. It is particularly beneficial for patients with co-existing heart failure or chronic kidney disease, and has been shown to reduce hospitalization risk due to heart failure.

As an immediate-release (IR) formulation, it is designed for rapid absorption and onset of action. It is generally used as monotherapy or in combination with other antidiabetic agents such as metformin, DPP-4 inhibitors, or insulin.

Tags:

Type 2 Diabetes SGLT2 Inhibitors Oral Antidiabetics Immediate Release Cardio-Renal Protection Prescription Medicines
  • Reduces blood glucose by promoting urinary excretion of glucose
  • Provides cardiovascular benefits in diabetic patients with heart conditions
  • Helps lower systolic blood pressure
  • Aids in modest weight reduction
  • Offers renal protection in diabetic nephropathy

Usage Information

Dosage

Recommended Dose: 10mg once daily, taken in the morning with or without food. Your doctor may adjust the dose based on your glucose levels and kidney function. Maintain adequate hydration during therapy.

Side Effects

Common side effects: Increased urination Genital or urinary tract infections Thirst and dehydration Mild weight loss Serious but rare side effects: Ketoacidosis (even with normal blood sugar) Hypotension Impaired renal function Fournier’s gangrene (very rare, life-threatening infection)

Contraindications

Type 1 diabetes Diabetic ketoacidosis (DKA) Severe renal impairment (eGFR < 30 mL/min/1.73m²) Hypersensitivity to Empagliflozin Patients with frequent urinary tract infections or dehydration risk

Availability

Empagliflozin 10mg tablet SGLT2 inhibitor for diabetes Empagliflozin IR diabetes medication Type 2 diabetes kidney glucose excretion Blood sugar lowering SGLT2 medicine Empagliflozin heart failure benefit Oral antidiabetic empagliflozin Empagliflozin dosage and side effects

Empagliflozin 10mg IR Tablet – SGLT2 Inhibitor for Type 2 Diabetes | Intralife Pharmaceuticals | Intralife